Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/10766175

Cancer Res. 2000 Apr 1 60 7 1878-86

Download in:

View as

General Info

PMID
10766175